Atlas Venture Fund VII L P

This profile gathers the share dealings of Atlas Venture Fund VII L P across 3 companies, led by Larimar Therapeutics, Inc., Egalet Corp and Oruka Therapeutics, Inc. In total, 14 filings cover trades dated from 29 March 2010 to 29 June 2018.

The open-market side counts 1 purchase for €366k alongside 1 sale for €788k. On balance, insiders were net sellers of €422k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.

The newest entry dates from 2 July 2018: a transaction, in Larimar Therapeutics, Inc. The clock since the last published purchase (12 February 2014) now reads 4,653 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.